免疫疗法的当前状况。 - Suppr

Suppr

超能文献

Current status of immunotherapy.

作者信息

Coates A

出版信息

Drugs. 1974;8(6):405-7. doi: 10.2165/00003495-197408060-00002.

DOI:10.2165/00003495-197408060-00002

PMID:4616826

Abstract

摘要

相似文献

Current status of immunotherapy.

Drugs. 1974;8(6):405-7. doi: 10.2165/00003495-197408060-00002.

Immunotherapy of cancer in man.

Am Sci. 1976 Jul-Aug;64(4):418-23.

Current state of clinical immunotherapy.

Transplant Proc. 1979 Mar;11(1):1077-81.

[Current status of immunotherapy of malignant tumors].

Chirurg. 1979 Jan;50(1):11-5.

Immunotherapy of cancer in man: current status and prospectus.

Ann N Y Acad Sci. 1976;277(00):722-40. doi: 10.1111/j.1749-6632.1976.tb41745.x.

[Immunotherapy of cancer: evolution of concepts and clinical advances].

Rev Prat. 1980 Jan 21;30(5):221-4, 227-8.

Immunotherapy of solid tumor.

Surg Clin North Am. 1979 Apr;59(2):371-80. doi: 10.1016/s0039-6109(16)41790-1.

Immunotherapy of cancer.

West J Med. 1977 Feb;126(2):102-9.

Tumor immunotherapy: current trials and future developments.

Semin Oncol. 1974 Dec;1(4):425-7.

Immunotherapy of gastrointestinal cancer: the potential.

Clin Gastroenterol. 1976 Sep;5(3):855-68.

本文引用的文献

Tumor-specific transplantation antigens: G. H. A. Clowes memorial lecture.

Cancer Res. 1968 Apr;28(4):625-35.

BCG immunotherapy of a rat sarcoma.

Br J Cancer. 1973 Oct;28(4):281-7. doi: 10.1038/bjc.1973.149.

Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Adv Immunol. 1974;18:209-77. doi: 10.1016/s0065-2776(08)60311-9.

Implications of cancer immunity.

Aust N Z J Med. 1973 Feb;3(1):71-7. doi: 10.1111/j.1445-5994.1973.tb03959.x.

Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.

J Natl Cancer Inst. 1973 Jan;50(1):159-72. doi: 10.1093/jnci/50.1.159.

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Br J Cancer. 1969 Dec;23(4):814-24. doi: 10.1038/bjc.1969.101.

Immunotherapy for acute myelogenous leukaemia.

Br J Cancer. 1973 Nov;28(5):365-76. doi: 10.1038/bjc.1973.162.

Active immunotherapy for acute lymphoblastic leukaemia.

Lancet. 1969 Apr 5;1(7597):697-9. doi: 10.1016/s0140-6736(69)92648-8.

Active immunotherapy with B.C.G. for recurrent malignant melanoma.

Lancet. 1973 Jun 2;1(7814):1208-12. doi: 10.1016/s0140-6736(73)90526-6.

Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.

Br J Cancer. 1972 Jun;26(3):141-53. doi: 10.1038/bjc.1972.21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Current status of immunotherapy.

Drugs. 1974;8(6):405-7. doi: 10.2165/00003495-197408060-00002.

Immunotherapy of cancer in man.

Am Sci. 1976 Jul-Aug;64(4):418-23.

Current state of clinical immunotherapy.

Transplant Proc. 1979 Mar;11(1):1077-81.

[Current status of immunotherapy of malignant tumors].

Chirurg. 1979 Jan;50(1):11-5.

Immunotherapy of cancer in man: current status and prospectus.

Ann N Y Acad Sci. 1976;277(00):722-40. doi: 10.1111/j.1749-6632.1976.tb41745.x.

[Immunotherapy of cancer: evolution of concepts and clinical advances].

Rev Prat. 1980 Jan 21;30(5):221-4, 227-8.

Immunotherapy of solid tumor.

Surg Clin North Am. 1979 Apr;59(2):371-80. doi: 10.1016/s0039-6109(16)41790-1.

Immunotherapy of cancer.

West J Med. 1977 Feb;126(2):102-9.

Tumor immunotherapy: current trials and future developments.

Semin Oncol. 1974 Dec;1(4):425-7.

Immunotherapy of gastrointestinal cancer: the potential.

Clin Gastroenterol. 1976 Sep;5(3):855-68.

本文引用的文献

Tumor-specific transplantation antigens: G. H. A. Clowes memorial lecture.

Cancer Res. 1968 Apr;28(4):625-35.

BCG immunotherapy of a rat sarcoma.

Br J Cancer. 1973 Oct;28(4):281-7. doi: 10.1038/bjc.1973.149.

Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Adv Immunol. 1974;18:209-77. doi: 10.1016/s0065-2776(08)60311-9.

Implications of cancer immunity.

Aust N Z J Med. 1973 Feb;3(1):71-7. doi: 10.1111/j.1445-5994.1973.tb03959.x.

Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.

J Natl Cancer Inst. 1973 Jan;50(1):159-72. doi: 10.1093/jnci/50.1.159.

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Br J Cancer. 1969 Dec;23(4):814-24. doi: 10.1038/bjc.1969.101.

Immunotherapy for acute myelogenous leukaemia.

Br J Cancer. 1973 Nov;28(5):365-76. doi: 10.1038/bjc.1973.162.

Active immunotherapy for acute lymphoblastic leukaemia.

Lancet. 1969 Apr 5;1(7597):697-9. doi: 10.1016/s0140-6736(69)92648-8.

Active immunotherapy with B.C.G. for recurrent malignant melanoma.

Lancet. 1973 Jun 2;1(7814):1208-12. doi: 10.1016/s0140-6736(73)90526-6.

Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.

Br J Cancer. 1972 Jun;26(3):141-53. doi: 10.1038/bjc.1972.21.